TACT: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Official Title== | ==Official Title== | ||
Trial to Assess Chelation Therapy (TACT) | |||
==Objective== | ==Objective== | ||
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. | |||
==Sponsor== | ==Sponsor== | ||
Mt. Sinai Medical Center, Miami | |||
==Timeline== | ==Timeline== | ||
| Line 17: | Line 18: | ||
| Colspan="2" style="background:Gainsboro" align="center"|'''Timeline''' | | Colspan="2" style="background:Gainsboro" align="center"|'''Timeline''' | ||
|- | |- | ||
| Style="width:30%"| '''Start Date'''||Style="width:70%"| | | Style="width:30%"| '''Start Date'''||Style="width:70%"|September 2003 | ||
|- | |- | ||
| '''Run-In Period'''|| | | '''Run-In Period'''||August 2012 | ||
|- | |- | ||
| '''End Date'''|| | | '''End Date'''||October 2011 | ||
|- | |- | ||
| '''Status'''|| | | '''Status'''|| Completed | ||
|- | |- | ||
|} | |} | ||
| Line 34: | Line 35: | ||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Description''' | | Colspan="2" style="background:Gainsboro" align="center"|'''Study Description''' | ||
|- | |- | ||
| Style="width:30%"|'''Study Type'''|| Style="width:70%"| | | Style="width:30%"|'''Study Type'''|| Style="width:70%"|Interventional | ||
|- | |- | ||
| '''Study Phase''' || | | '''Study Phase''' || | ||
| Line 40: | Line 41: | ||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Design''' | | Colspan="2" style="background:Gainsboro" align="center"|'''Study Design''' | ||
|- | |- | ||
| '''Allocation'''|| | | '''Allocation'''||Randomized | ||
|- | |- | ||
| '''Endpoint'''|| | | '''Endpoint'''|| Efficacy Study | ||
|- | |- | ||
| '''Interventional Model'''|| | | '''Interventional Model'''|| Factorial Assignment | ||
|- | |- | ||
| '''Masking'''|| | | '''Masking'''||Double Blind (Subject, Investigator) | ||
|- | |- | ||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Details''' | | Colspan="2" style="background:Gainsboro" align="center"|'''Study Details''' | ||
|- | |- | ||
| '''Primary Purpose'''|| | | '''Primary Purpose'''||Treatment | ||
|- | |- | ||
| '''Condition'''|| | | '''Condition'''|| | ||
Revision as of 18:04, 19 November 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
TACT On the Web |
|
American Roentgen Ray Society Images of TACT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Official Title
Trial to Assess Chelation Therapy (TACT)
Objective
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Sponsor
Mt. Sinai Medical Center, Miami
Timeline
| Timeline | |
| Start Date | September 2003 |
| Run-In Period | August 2012 |
| End Date | October 2011 |
| Status | Completed |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT------.
Study Description
| Study Description | |
| Study Type | Interventional |
| Study Phase | |
| Study Design | |
| Allocation | Randomized |
| Endpoint | Efficacy Study |
| Interventional Model | Factorial Assignment |
| Masking | Double Blind (Subject, Investigator) |
| Study Details | |
| Primary Purpose | Treatment |
| Condition | |
| Intervention | |
| Study Arms | |
| Population Size | |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT-----.